ARCHIVES

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Senate confirms McClellan to head CMS. NCI “redeploys” $54.5 million cut from divisions to fund strategic initiatives.

March 26, 2004

In Brief; “Sense of Urgency” In Research Is Theme of New AACR President Daniel Von Hoff

April 16, 1999

In Brief: XIIIth Congress Draws Record Number Of Abstracts, 3,000 Registrants So Far; Exhibit Area Sold Out

March 5, 1982

July issue of Business & Regulatory report (8 additional pages) included.

July 30, 2004

Cancer Survivors Day Planned or June 5

April 22, 1988

Cooperative Group Chairmen, OPRR Seek Agreement On Assurances

January 6, 1984